Atrium TherapeuticsRNA
那斯達克 · USD
9.50
-0.59
(-5.85%)
收盤 09/17 03:59 (UTC+8)
盤後
9.58
+0.08
(+0.84%)
09/17 03:59 (UTC+8)
Atrium TherapeuticsRNA
9.50
-0.59
(-5.85%)
財務數據
損益表
- 0.04
- 0.02
- 0.02
- 0.03
- 0.02
- 0.04
- 0.12
- 0.01
- 0.20
- 0.03
- 61.56
- -42.28
- 14.23
- 27.27
- -47.09
- 144.56
- 224.28
- -93.11
- 2185.80
- -84.70
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 3,004 | 19,635 | 859 | 12,475 | 3,847 | 1,573 | 2,973 | 2,336 | 2,045 | 3,543 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 3,004 | 19,635 | 860 | 12,475 | 3,847 | 1,573 | 2,973 | 2,336 | 2,045 | 3,543 |
營業費用 | 25,622 | 36,915 | 255,338 | 201,281 | 174,989 | 133,090 | 123,963 | 100,469 | - | 80,730 |
研發費用 | 15,343 | 16,657 | 166,596 | 154,948 | 138,125 | 99,490 | 95,625 | 77,196 | 63,940 | 66,832 |
推銷及管理費用 | 10,279 | 20,258 | 88,742 | 46,333 | 36,864 | 33,600 | 28,338 | 23,273 | 20,731 | 13,898 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -22,618 | -17,280 | -48,035 | -188,806 | -171,142 | -7,452 | -44,249 | -98,133 | -82,626 | -77,187 |
其他收入及費用 | - | - | 17,377 | 14,364 | 13,827 | 15,744 | 18,733 | 17,736 | 11,833 | 8,332 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -20,186 | -16,633 | -48,035 | -174,442 | -157,315 | -115,773 | -102,257 | -80,397 | -70,793 | -68,855 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -20,186 | -16,633 | -48,069 | -174,442 | -157,315 | -7,449 | -46,195 | -80,397 | -70,793 | -68,855 |
基本每股稅後盈餘(元) | -1.18 | -0.97 | -1.59 | -1.27 | -0.75 | -0.44 | -0.80 | -0.65 | -0.65 | -0.79 |
稀釋每股稅後盈餘(元) | -1.18 | -0.97 | -1.59 | -1.27 | -0.75 | -0.90 | -0.81 | -0.64 | -0.65 | -0.79 |
基本平均股數(千股) | 17106.00 | 17105.00 | 154091.00 | 137895.00 | 17106.00 | 17084.00 | 128497.00 | 123375.00 | 106928.00 | 87212.00 |
稀釋平均股數(千股) | 17106.00 | 17105.00 | 154091.00 | 137895.00 | 17106.00 | 17124.00 | 128497.00 | 123375.00 | 106928.00 | 87212.00 |
還原基本每股稅後盈餘(元) | -1.18 | -0.97 | -1.59 | -1.27 | -0.75 | -0.44 | -0.80 | -0.65 | -0.65 | -0.79 |
還原稀釋每股稅後盈餘(元) | -1.18 | -0.97 | -1.59 | -1.27 | -0.75 | -0.90 | -0.81 | -0.64 | -0.65 | -0.79 |
還原基本平均股數(千股) | 17,106 | 17,105 | 154,091 | 137,895 | 17,106 | 17,084 | 128,497 | 123,375 | 106,928 | 87,212 |
還原稀釋平均股數(千股) | 17,106 | 17,105 | 154,091 | 137,895 | 17,106 | 17,124 | 128,497 | 123,375 | 106,928 | 87,212 |
EBITDA(千元) | -19,843 | -16,482 | -48,060 | -175,791 | -159,976 | -11,821 | -52,623 | -86,533 | -74,581 | -71,174 |